XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
  UK
  USA
  World
  India
   Madhya Pradesh
   Medical Tourism
  South Africa
  New Zealand
  Australia
  Canada Healthcare
  China Healthcare
  Africa
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

New Journal Launched - Diabetes Research & Metabolic Syndrome

India Channel
subscribe to India newsletter

Medical News : Healthcare : India

   DISCUSS   |   EMAIL   |   PRINT
Elsevier partners with Diabetes India
Nov 17, 2005, 16:35, Reviewed by: Dr.

"We will focus on issues relating to these diseases in South Asia, China, Africa and the Middle East where 60 to 70% of the world population and diabetes patients reside--and which are sparsely represented in the mainstream diabetes journals. I am thrilled to be working with the editorial board whose members represent global leadership in diabetes and metabolic disorders, from both developed and developing countries."

 
Elsevier, the world-leading scientific and medical publisher, has announced a new publishing partnership with Diabetes India (DI) and the launch of a new journal, Diabetes Research & Metabolic Syndrome in June 2006. Diabetes Research & Metabolic Syndrome will cover two main clinical areas--diabetes and metabolic syndrome focusing on both vascular damage causes and the glucose centered disease approach.

Editor of Diabetes Research & Metabolic Syndrome, Professor Philip Home noted, "Metabolic Syndrome is of particular interest from a global perspective and this gives Diabetes Research & Metabolic Syndrome its raison d'etre in an era of proliferating specialist journals in the field of diabetes. The journal is timely and should rapidly become a force in the world of cardiovascular prevention."

"Despite the growing importance of diabetes and the metabolic syndrome worldwide, only a few medical journals are actually dedicated to these diseases," explained Co-Editor, Professor Anoop Misra further, "We will focus on issues relating to these diseases in South Asia, China, Africa and the Middle East where 60 to 70% of the world population and diabetes patients reside--and which are sparsely represented in the mainstream diabetes journals. I am thrilled to be working with the editorial board whose members represent global leadership in diabetes and metabolic disorders, from both developed and developing countries."
 

- Elsevier
 

www.elsevier.com

 
Subscribe to India Newsletter
E-mail Address:

 

About DiabetesIndia
DIABETESINDIA originally named as The Indian Task Force on Diabetes Care In India was initially formed by a group of around 400 practicing diabetologists and has now opened its doors to other medical specialists, family physicians, people with diabetes and all others interested in the cause of diabetes. Today, we are proud to say that we have a membership of many thousands and this is increasing at a rapid pace. DIABETESINDIA recently carried out a first of its kind nationwide survey of the prevalence of diabetes and our published data shows that India has already exceeded the WHO projections. For more information please visit http://diabetesindia.com

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's nearly 7,000 employees in 77 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as Science Direct (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.news.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Related India News

Indian scientists develop Elisa tests for avian influenza
Delhi reports 222 cholera cases in four months
Over 200,000 miners in Rajasthan suffer from silicosis
Doctors join hands to spread message of safe motherhood
Hindustan Latex launches first female condom
Chhattisgarh to become eco-tourism hub
Obesity cure lures foreigners to India
Change behaviour to combat AIDS
India to introduce rating system for hospitals
Japanese trust to train leprosy cured people in India


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us